Industries We Govern / Medical Devices and Wearables
MEDICAL DEVICES AND WEARABLES

In medical programmes, late discovery is not recoverable.

Regulatory submission timelines are fixed. Design freeze is non-negotiable. First-off sample failures do not just cost money. They cost approvals.

30
YEARS EXPERIENCE
3,000+
PROJECTS GOVERNED
2003
CHINA OPERATIONS
Rs.20-150Cr
REVENUE AT STAKE PER PROJECT

Your products are not competing with European and Western quality standards.

China is moving ahead. The gap is not capability. The gap is governance.

The plastic enclosure is not packaging. It is as regulated as the electronics.

Medical device founders with electronics backgrounds treat the housing as secondary. It gets approved quickly. Then assembly happens, fitment is off, and the rated performance cannot be validated because the physical product was never properly governed.

The brief was incomplete. Nobody caught it before manufacturing. And at that point, the regulatory clock has already started.

Most medical device tooling failures were decided before steel was cut. They were just not visible yet.

THE PATTERN IN ALMOST EVERY MEDICAL PROGRAMME

Good people. Right investment.

Product still not ready.

Design changes that never officially stop
Freeze happens on paper. Changes continue informally. Nobody owns the version.
Regulatory risk discovered at trial
A design change after submission means 12 to 18 months of lost time.
Supplier selected on cost, not capability
No technical qualification. Issues discovered after tooling is awarded and money is spent.
Freelancers and agencies disappear
When problems surface, there is no one to call back. No governance continuity.
Physical product blind spot
Someone assumes the enclosure brief is complete. Nothing fits at assembly.
Nobody owns the programme outcome
Designer designed, manufacturer built, someone else shipped. Nobody owns the result.
The first product is personal
Investor visibility. Team pride. Patient ambitions. Failure is not a setback. It is a collapse.
FROM AUDITS THAT ALL MEDICAL DEVICE PROGRAMMES REQUESTED

The cost nobody calculates. Until it is too late.

Unverified supplier selection

Suppliers chosen on price. Technical capability never verified. Problems surface at trial, after commitment is made.

No programme governance owner

Design, engineering, tooling, manufacturing each have an owner. The connection between them does not. This is where medical programmes fail.

Decisions without consequence visibility

Early decisions taken without understanding their downstream impact on tooling, trials, and regulatory timelines.

No China governance structure

Tooling sourced from China without a governance layer. Suppliers deliver to their standard. Not yours.

INDEPENDENT OF TEAM SIZE, EVERY MEDICAL DEVICE PROGRAMME CARRIES THE SAME GAP

Every team configuration carries the same gap.

LARGE INTERNAL TEAM

Every function has a person. Design, engineering, procurement, quality. Everyone is doing their job.

The gap between functions still exists. Nobody owns the outcome.

SMALL INTERNAL TEAM

When one or two people managing multiple functions, heavy reliance on freelancers and agencies across different stages.

When one person exits, programme momentum goes with them.

NO INTERNAL TEAM

Founder managing all vendors directly. Design agency, engineering freelancer, tooling supplier working without a governance layer.

No one is watching the gap. Nobody was hired to.

Governance is not a replacement for your team. It is what makes every team configuration work better.

With governance. Without governance.

WITHOUT GOVERNANCE

Design changes keep coming informally after freeze.

Supplier issues surface at trial. Problems discovered at trials.

Regulatory requirements discovered after commitment is made.

Teams handoff between agencies creates an unmanaged gap.

China supplier remains to their standard. Not yours.

WITH GOVERNANCE

Design freeze is real. Every change assessed before approval.

Supplier capability verified before tooling is awarded.

Regulatory timeline built into every governance decision.

One authority holds programme visibility across all stages.

China sourcing under governance. Not open market without accountability.

"We had good people on every part of the programme. The product still did not come out right. And we still are not sure exactly why."

A medical device programme founder. The project is about three years behind where they expected.

Taurus Healthcare

"Flawless production and excellent after sales service was provided by the team."

TAURUS HEALTHCARE PVT. LTD.
K.C. Dwivedi

"I am thankful to Mr. Jagdip for helping us save approximately 39 lakhs for our Injection Mould Project."

COMBOSEAL INDUSTRIES PVT. LTD.

Who this is relevant for

RELEVANT PROGRAMME TYPES

Diagnostic and imaging equipment

Patient monitoring devices and wearables

Drug delivery and infusion systems

Surgical and intervention instruments

Telemedicine and remote monitoring

AI-enabled medical devices and diagnostics

RELEVANT IF YOU ARE FACING

Regulatory timelines that cannot absorb delays

Design changes still happening informally

First product launch with no governance structure in place

Supplier not independently validated

Programme continuity depending on freelancers

First-off sample failures would carry regulatory consequences

GOVERNANCE LEVELS FOR MEDICAL PROGRAMMES

Depending on programme complexity and risk, governance is structured across three levels: LaunchGuard, ToolLock Control, and ToolLock Lite.

See Programme Details →

Where do you want to go next

READY TO TALK

Start a Structured Discussion

Twenty minutes. No quotation.

SEE INDUSTRIES WE GOVERN

Industries We Govern

See how the same governance principles apply across Appliances, Automotive, and Consumer Electronics.